Analysis for the potential of polystyrene and TiO2 nanoparticles to induce skin irritation, phototoxicity, and sensitization
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Yoon-Hee | - |
dc.contributor.author | Jeong, Sang Hoon | - |
dc.contributor.author | Yi, Sang Min | - |
dc.contributor.author | Choi, Byeong Hyeok | - |
dc.contributor.author | Kim, Yu-Ri | - |
dc.contributor.author | Kim, In-Kyoung | - |
dc.contributor.author | Kim, Meyoung-Kon | - |
dc.contributor.author | Son, Sang Wook | - |
dc.date.accessioned | 2021-09-07T05:43:19Z | - |
dc.date.available | 2021-09-07T05:43:19Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2011-12 | - |
dc.identifier.issn | 0887-2333 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/111062 | - |
dc.description.abstract | The human skin equivalent model (HSEM) is well known as an attractive alternative model for evaluation of dermal toxicity. However, only limited data are available on the usefulness of a HSEM for nanotoxicity testing. This study was designed to investigate cutaneous toxicity of polystyrene and TiO2 nanoparticles using cultured keratinocytes, a HSEM, and an animal model. In addition, we also evaluated the skin sen-sitization potential of nanoparticles using a local lymph node assay with incorporation of BrdU. Findings from the present study indicate that polystyrene and TiO2 nanoparticles do not induce phototoxicity, acute cutaneous irritation, or skin sensitization. Results from evaluation of the HSEMs correspond well with those from animal models. Our findings suggest that the HSEM might be a useful alternative model for evaluation of dermal nanotoxicity. (C) 2011 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | QUANTUM DOTS | - |
dc.subject | IN-VITRO | - |
dc.subject | CYTOTOXICITY | - |
dc.subject | TOXICITY | - |
dc.subject | MODEL | - |
dc.subject | DRUG | - |
dc.subject | PENETRATION | - |
dc.subject | EPISKIN(R) | - |
dc.subject | PARTICLES | - |
dc.subject | OXIDE | - |
dc.title | Analysis for the potential of polystyrene and TiO2 nanoparticles to induce skin irritation, phototoxicity, and sensitization | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Byeong Hyeok | - |
dc.contributor.affiliatedAuthor | Son, Sang Wook | - |
dc.identifier.doi | 10.1016/j.tiv.2011.05.022 | - |
dc.identifier.scopusid | 2-s2.0-82655174047 | - |
dc.identifier.wosid | 000298362500045 | - |
dc.identifier.bibliographicCitation | TOXICOLOGY IN VITRO, v.25, no.8, pp.1863 - 1869 | - |
dc.relation.isPartOf | TOXICOLOGY IN VITRO | - |
dc.citation.title | TOXICOLOGY IN VITRO | - |
dc.citation.volume | 25 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1863 | - |
dc.citation.endPage | 1869 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | QUANTUM DOTS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | CYTOTOXICITY | - |
dc.subject.keywordPlus | TOXICITY | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordPlus | DRUG | - |
dc.subject.keywordPlus | PENETRATION | - |
dc.subject.keywordPlus | EPISKIN(R) | - |
dc.subject.keywordPlus | PARTICLES | - |
dc.subject.keywordPlus | OXIDE | - |
dc.subject.keywordAuthor | Polystyrene | - |
dc.subject.keywordAuthor | TiO2 | - |
dc.subject.keywordAuthor | Phototoxicity | - |
dc.subject.keywordAuthor | Skin irritation | - |
dc.subject.keywordAuthor | Skin sensitization | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.